Business● LowJun 30 · Jun 30, 2026, 6:52 PM
Bristol, Merck, AbbVie face House committee probe over China trials
GlobeAlert Desk · curated from Seeking Alpha Tech
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business16m agoHaryana power discoms seek review of licenceThe HinduBusiness29m agoArista forecasts $18.5B FY 2027 revenue amid 38%-40% growth outlook and $7B AI fabrics targetSeeking Alpha TechBusiness49m agoFlywire outlines 25%-27% 2026 FX-neutral revenue growth as it targets 25% adjusted EBITDA margin in 2027Seeking Alpha TechBusiness49m agoDuolingo expects Q4 2026 bookings +13% and $84M adjusted EBITDA while rolling out Video Call to all paid subscribersSeeking Alpha Tech